CVE-2023-40279

Exploitation

Public exploit code exists. CISA's assessment records a public proof of concept. That is not a report of exploitation in the wild.

SSVC decision

• ExploitationpocPublic proof-of-concept exploit code exists. Not a report of exploitation in the wild.
• AutomatableyesAn attacker can reliably automate reconnaissance through exploitation, so this scales.
• Technical ImpactpartialSuccessful exploitation gives limited control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

3.38% probability of exploitation activity in the next 30 days.

EPSS percentile

Ranks above 87.7% of scored records. A rank, not a probability.

NVD base score

7.5 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

NVD analysis status

Analyzed. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2024-03-19 00:00Z2 YR AGO

Last updated

2025-04-10 20:19Z1 YR AGO

Reserved

2023-08-14

Assigning CNA

mitre

Record state

PUBLISHED

Severity

High (CVSS 7.5)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Weaknesses

• CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')Base

Data version

5.1

Document digest

1cfbe48e41de70a0676d076d59893e51d04fbc49847589ce875ca5c486847b71

• sourceforge.nethttps://sourceforge.net/projects/open-clinic/
• github.comhttps://github.com/BugBountyHunterCVE/CVE-2023-40279/blob/main/CVE-2023-40279_Authenticated-Directory-Path-Traversal_OpenClinic-GA_5.247.01_Report.md